• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织型纤溶酶原激活剂在人眼和猴眼中的分布。一项免疫组织化学研究。

Distribution of tissue plasminogen activator in human and monkey eyes. An immunohistochemical study.

作者信息

Tripathi B J, Geanon J D, Tripathi R C

机构信息

Department of Ophthalmology and Visual Science, University of Chicago, IL.

出版信息

Ophthalmology. 1987 Nov;94(11):1434-8. doi: 10.1016/s0161-6420(87)33278-6.

DOI:10.1016/s0161-6420(87)33278-6
PMID:3120076
Abstract

The authors examined various structures of human and rhesus monkey eyes for the presence of tissue plasminogen activator (t-PA) by using the peroxidase-antiperoxidase immunohistochemical technique with a monoclonal antibody specific for human t-PA. Positive staining for t-PA was observed both intracellularly and in the extracellular matrix of many tissues in both species. The tissues which stained intensely for t-PA included the corneal endothelium, corneal epithelium, trabecular meshwork, lens epithelium, peripheral vitreous, uveal tract, inner retina, and all vascular endothelia. The apparent minor difference in staining intensity between human and monkey eyes may be related to the time-dependent degradation of t-PA, to variations in the tissue content of t-PA, or to the difference in animal species. The discussion includes a consideration of the fibrinolytic activity of t-PA and of its emerging role in the destructive remodeling of the extracellular matrix in various ocular structures.

摘要

作者使用针对人组织型纤溶酶原激活剂(t-PA)的单克隆抗体,采用过氧化物酶-抗过氧化物酶免疫组织化学技术,检测了人眼和恒河猴眼的各种结构中是否存在t-PA。在这两个物种的许多组织的细胞内和细胞外基质中均观察到t-PA的阳性染色。t-PA染色强烈的组织包括角膜内皮、角膜上皮、小梁网、晶状体上皮、周边玻璃体、葡萄膜、视网膜内层以及所有血管内皮。人眼和猴眼在染色强度上的明显细微差异可能与t-PA的时间依赖性降解、t-PA的组织含量变化或动物物种差异有关。讨论内容包括对t-PA的纤溶活性及其在各种眼部结构的细胞外基质破坏性重塑中新兴作用的思考。

相似文献

1
Distribution of tissue plasminogen activator in human and monkey eyes. An immunohistochemical study.组织型纤溶酶原激活剂在人眼和猴眼中的分布。一项免疫组织化学研究。
Ophthalmology. 1987 Nov;94(11):1434-8. doi: 10.1016/s0161-6420(87)33278-6.
2
Localization of urokinase-type plasminogen activator in human eyes: an immunocytochemical study.人眼中尿激酶型纤溶酶原激活剂的定位:一项免疫细胞化学研究。
Exp Eye Res. 1990 Nov;51(5):545-52. doi: 10.1016/0014-4835(90)90085-9.
3
Tissue plasminogen activator in the lens.晶状体中的组织型纤溶酶原激活剂。
Ophthalmic Res. 1988;20(3):160-3. doi: 10.1159/000266578.
4
Fibrinolytic activity and localization of plasminogen activator in bovine vitreous body and aqueous humor.牛玻璃体和房水中纤溶活性及纤溶酶原激活物的定位
Jpn J Ophthalmol. 1989;33(1):66-75.
5
Tissue plasminogen activator in avascular tissues of the eye: a quantitative study of its activity in the cornea, lens, and aqueous and vitreous humors of dog, calf, and monkey.
Exp Eye Res. 1987 Jan;44(1):55-63. doi: 10.1016/s0014-4835(87)80025-8.
6
Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.组织型和尿激酶型纤溶酶原激活剂以及纤溶酶原激活剂抑制剂-1和-2在人和恒河猴胎盘中的表达
J Anat. 1999 Feb;194 ( Pt 2)(Pt 2):183-95. doi: 10.1046/j.1469-7580.1999.19420183.x.
7
Production of proteases type plasminogen activator and their inhibitor in cornea.角膜中纤溶酶原激活物型蛋白酶及其抑制剂的产生。
Biochem Biophys Res Commun. 1989 May 15;160(3):1021-5. doi: 10.1016/s0006-291x(89)80104-4.
8
Hormonal regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 in cultured monkey Sertoli cells.培养的猴支持细胞中组织型纤溶酶原激活物和纤溶酶原激活物抑制剂-1的激素调节
Hum Reprod. 1995 Mar;10(3):719-27.
9
Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.培养的角膜和主动脉内皮细胞产生的细胞外基质含有活性组织型和尿激酶型纤溶酶原激活剂。
J Cell Physiol. 1993 Mar;154(3):456-65. doi: 10.1002/jcp.1041540303.
10
Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.人腹膜间皮细胞的纤溶活性因组织型纤溶酶原激活物的快速摄取而受到抑制。
Kidney Int. 1999 Jan;55(1):120-9. doi: 10.1046/j.1523-1755.1999.00244.x.

引用本文的文献

1
Historical and Contemporary Debates in Schlemm's Canal-Based MIGS.基于施莱姆管的微切口白内障手术的历史与当代争论
J Clin Med. 2024 Aug 19;13(16):4882. doi: 10.3390/jcm13164882.
2
Effect of SPARC Suppression in Mice, Perfused Human Anterior Segments, and Trabecular Meshwork Cells.SPARC 抑制对小鼠、灌注人眼前段和小梁细胞的影响。
Invest Ophthalmol Vis Sci. 2022 Jun 1;63(6):8. doi: 10.1167/iovs.63.6.8.
3
Tissue plasminogen activator rescues steroid-induced outflow facility reduction via non-enzymatic action.组织型纤溶酶原激活物通过非酶促作用挽救了皮质类固醇诱导的流出道通畅度降低。
Mol Vis. 2021 Dec 7;27:691-705. eCollection 2021.
4
Investigations on the Role of the Fibrinolytic Pathway on Outflow Facility Regulation.纤溶途径在流出道调节中的作用研究。
Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1571-1580. doi: 10.1167/iovs.18-25698.
5
Anterior chamber fibrinoid syndrome after cataract extraction in a patient on ibrutinib for B-cell chronic lymphocytic leukemia: a case report and review of the literature.1例接受伊布替尼治疗B细胞慢性淋巴细胞白血病的患者白内障摘除术后前房纤维蛋白样综合征:病例报告及文献复习
J Med Case Rep. 2018 Nov 16;12(1):349. doi: 10.1186/s13256-018-1822-9.
6
Enzymatic vitreolysis with recombinant tissue plasminogen activator for vitreomacular traction.重组组织型纤溶酶原激活剂用于酶解玻璃体黄斑牵引
Drug Des Devel Ther. 2015 Nov 27;9:6259-68. doi: 10.2147/DDDT.S88361. eCollection 2015.
7
The Naïve Murine Cornea as a Model System to Identify Novel Endogenous Regulators of Lymphangiogenesis: TRAIL and rtPA.作为鉴定淋巴管生成新内源性调节因子的模型系统的幼稚小鼠角膜:肿瘤坏死因子相关凋亡诱导配体(TRAIL)和重组组织型纤溶酶原激活剂(rtPA)
Lymphat Res Biol. 2015 Jun;13(2):76-84. doi: 10.1089/lrb.2015.0004.
8
Tissue plasminogen activator in trabecular meshwork attenuates steroid induced outflow resistance in mice.小梁网中的组织型纤溶酶原激活剂可减轻小鼠类固醇诱导的房水流出阻力。
PLoS One. 2013 Aug 19;8(8):e72447. doi: 10.1371/journal.pone.0072447. eCollection 2013.
9
Intracameral concentrations of the fibrinolytic system components in patients with age-related macular degeneration.年龄相关性黄斑变性患者房水中纤维蛋白溶解系统成分的浓度。
Graefes Arch Clin Exp Ophthalmol. 2013 Dec;251(12):2697-704. doi: 10.1007/s00417-013-2374-8. Epub 2013 May 12.
10
Plasminogen activators promote excitotoxicity-induced retinal damage.纤溶酶原激活剂会促进兴奋性毒性诱导的视网膜损伤。
FASEB J. 2005 Aug;19(10):1280-9. doi: 10.1096/fj.04-3403com.